Abstract
Binder jetting (BJ) three-dimensional (3D) printing is becoming an established additive manufacturing technology for manufacturing of solid products for oral drug delivery. Similar to traditional solutions based on compaction of powder mixture, successful processing of BJ products requires control of bulk powder properties. In contrast to traditional compaction-based process, BJ 3D printing allows for flexible modifications on microstructure, material composition and dose in the printed pharmaceutical products. Currently, systematic strategies for selecting excipients and optimizing the printing process have not been fully established. To address this challenge, a summary of the published work and selected patent literature around BJ 3D printing to fabricate pharmaceutical solid products for oral administration purposes is presented. First, an overview of characteristics of printed products as a part of the product design and a description of the commonly used excipients and active pharmaceutical ingredients is given. The critical powder and ink properties, as well as physical geometries and inner structures of a final product, are discussed in term of the mechanisms that determine the formation of a printed solid product and finally the quality of this product. This review is also summarizing the technical features of printers, printheads, and the critical considerations for post-processing procedures. BJ 3D printing is one of the most promising additive manufacturing technologies for mass customization of pharmaceutical products.
Graphical Abstract
Similar content being viewed by others
Abbreviations
- 3D:
-
Three-dimensional
- AM:
-
Additive manufacturing
- API:
-
Active pharmaceutical ingredient
- BCS:
-
Biopharmaceutics Classification System
- BJ:
-
Binder jetting
- FDA:
-
US Food and Drug Administration
- FDM:
-
Fused deposition modeling
- HPC:
-
Hydroxypropyl cellulose
- LM:
-
Lactose monohydrate
- MJ:
-
Material jetting
- Oh :
-
Ohnesorge number
- PVP :
-
Polyvinyl pyrrolidone
- Re :
-
Reynolds number
- We :
-
Weber number
References
Dilberoglu UM, Gharehpapagh B, Yaman U, Dolen M. The role of additive manufacturing in the era of Industry 4.0. Proc Manuf. 2017;11:545–54. https://doi.org/10.1016/j.promfg.2017.07.148.
Jamroz W, Szafraniec J, Kurek M, Jachowicz R. 3D printing in pharmaceutical and medical applications-recent achievements and challenges. Pharm Res. 2018;35(9):176. https://doi.org/10.1007/s11095-018-2454-x.
Wu BM, Borland SW, Giordano RA, Cima LG, Sachs EM, Cima MJ. Solid free-form fabrication of drug delivery devices. J Control Release. 1996;40(1-2):77–87. https://doi.org/10.1016/0168-3659(95)00173-5.
Norman J, Madurawe RD, Moore CMV, Khan MA, Khairuzzaman A. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv Drug Deliv Rev. 2017;108:39–50. https://doi.org/10.1016/j.addr.2016.03.001.
Fitzgerald S. FDA approves first 3D-printed epilepsy drug experts assess the benefits and caveats. Neurol Today. 2015;15(18):26–7. https://doi.org/10.1097/01.NT.0000472137.66046.b5.
Boudriau S, Hanzel C, Massicotte J, Sayegh L, Wang J, Lefebvre M. Randomized comparative bioavailability of a novel three-dimensional printed fast-melt formulation of levetiracetam following the administration of a single 1000-mg dose to healthy human volunteers under fasting and fed conditions. Drugs R D. 2016;16(2):229–38. https://doi.org/10.1007/s40268-016-0132-1.
Chang S-Y, Li SW, Kowsari K, Shetty A, Sorrells L, Sen K, et al. Binder-jet 3D printing of indomethacin-laden pharmaceutical dosage forms. J Pharm Sci. 2020;109(10):3054–63. https://doi.org/10.1016/j.xphs.2020.06.027.
Wang Z, Han X, Chen R, Li J, Gao J, Zhang H, et al. Innovative color jet 3D printing of levetiracetam personalized paediatric preparations. Asian J Pharm Sci. 2021;16(3):374–86. https://doi.org/10.1016/j.ajps.2021.02.003.
Sachs E, Haggerty J, Cima M, Williams P. Three-dimensional printing techniques. US5204055A. 1989. https://patentimages.storage.googleapis.com/9e/92/4c/16485de942a672/US5204055.pdf
Sachs E, Cima M, Williams P, Brancazio D, Cornie J. Three dimensional printing: rapid tooling and prototypes directly from a CAD model. J Eng Ind. 1992;114(4):481–8. https://doi.org/10.1115/1.2900701.
Rowe CW, Wang C-C, Monkhouse DC. TheriForm technology. In: Rathbone MJ, Hadgraft J, Roberts MS, editors. Modified-release drug delivery technology. 2nd ed. Boca Raton: CRC Press; 2013. p. 77–87.
Kozakiewicz M, Nartowski KP, Dominik A, Malec K, Golkowska AM, Zlocinska A, et al. Binder jetting 3D printing of challenging medicines: From low dose tablets to hydrophobic molecules. Eur J Pharm Biopharm. 2021. https://doi.org/10.1016/j.ejpb.2021.11.001.
Antic A, Zhang J, Amini N, Morton D, Hapgood K. Screening pharmaceutical excipient powders for use in commercial 3D binder jetting printers. Adv Powder Technol. 2021;32(7):2469–83. https://doi.org/10.1016/j.apt.2021.05.014.
Chang SY, Jin J, Yan J, Dong X, Chaudhuri B, Nagapudi K, et al. Development of a pilot-scale HuskyJet binder jet 3D printer for additive manufacturing of pharmaceutical tablets. Int J Pharm. 2021;605:120791. https://doi.org/10.1016/j.ijpharm.2021.120791.
Wang Z, Li J, Hong X, Han X, Liu B, Li X, et al. Taste masking study based on an electronic tongue: the formulation design of 3D printed levetiracetam instant-dissolving tablets. Pharm Res. 2021;38(5):831–42. https://doi.org/10.1007/s11095-021-03041-9.
van den Heuvel KA, de Wit MT, Dickhoff BH. Evaluation of lactose based 3D powder bed printed pharmaceutical drug product tablets. Powder Technol. 2021;390:97–102. https://doi.org/10.1016/j.powtec.2021.05.050.
Sen K, Mukherjee R, Sansare S, Halder A, Kashi H, Ma AWK, et al. Impact of powder-binder interactions on 3D printability of pharmaceutical tablets using drop test methodology. Eur J Pharm Sci. 2021;160. https://doi.org/10.1016/j.ejps.2021.105755.
Sen K, Manchanda A, Mehta T, Ma AWK, Chaudhuri B. Formulation design for inkjet-based 3D printed tablets. Int J Pharm. 2020;584:119430. https://doi.org/10.1016/j.ijpharm.2020.119430.
Wilts EM, Ma D, Bai Y, Williams CB, Long TE. Comparison of Linear and 4-arm star poly(vinyl pyrrolidone) for aqueous binder jetting additive manufacturing of personalized dosage tablets. ACS Appl Mater Inter. 2019;11(27):23938–47. https://doi.org/10.1021/acsami.9b08116.
Tian P, Yang F, Yu LP, Lin MM, Lin W, Lin QF, et al. Applications of excipients in the field of 3D printed pharmaceuticals. Drug Dev Ind Pharm. 2019;45(6):905–13. https://doi.org/10.1080/03639045.2019.1576723.
Shi K, Tan DK, Nokhodchi A, Maniruzzaman M. Drop-on-powder 3D printing of tablets with an anti-cancer drug, 5-fluorouracil. Pharmaceutics. 2019;11(4):150. https://doi.org/10.3390/pharmaceutics11040150.
Infanger S, Haemmerli A, Iliev S, Baier A, Stoyanov E, Quodbach J. Powder bed 3D-printing of highly loaded drug delivery devices with hydroxypropyl cellulose as solid binder. Int J Pharm. 2019;555:198–206. https://doi.org/10.1016/j.ijpharm.2018.11.048.
Tian P, Yang F, Xu Y, Lin MM, Yu LP, Lin W, et al. Oral disintegrating patient-tailored tablets of warfarin sodium produced by 3D printing. Drug Dev Ind Pharm. 2018;44(12):1918–23. https://doi.org/10.1080/03639045.2018.1503291.
Yu DG, Shen XX, Branford-White C, Zhu LM, White K, Yang XL. Novel oral fast-disintegrating drug delivery devices with predefined inner structure fabricated by three-dimensional printing. J Pharm Pharmacol. 2009;61(3):323–9. https://doi.org/10.1211/jpp.61.03.0006.
Yu DG, Branford-White C, Yang YC, Zhu LM, Welbeck EW, Yang XL. A novel fast disintegrating tablet fabricated by three-dimensional printing. Drug Dev Ind Pharm. 2009;35(12):1530–6. https://doi.org/10.3109/03639040903059359.
Yu DG, Branford-White C, Ma ZH, Zhu LM, Li XY, Yang XL. Novel drug delivery devices for providing linear release profiles fabricated by 3DP. Int J Pharm. 2009;370(1-2):160–6. https://doi.org/10.1016/j.ijpharm.2008.12.008.
Yu DG, Yang XL, Huang WD, Liu J, Wang YG, Xu H. Tablets with material gradients fabricated by three-dimensional printing. J Pharm Sci. 2007;96(9):2446–56. https://doi.org/10.1002/jps.20864.
Wang CC, Tejwani Motwani MR, Roach WJ, Kay JL, Yoo J, Surprenant HL, et al. Development of near zero-order release dosage forms using three-dimensional printing (3-DP) technology. Drug Dev Ind Pharm. 2006;32(3):367–76. https://doi.org/10.1080/03639040500519300.
Lee KJ, Kang A, Delfino JJ, West TG, Chetty D, Monkhouse DC, et al. Evaluation of critical formulation factors in the development of a rapidly dispersing captopril oral dosage form. Drug Dev Ind Pharm. 2003;29(9):967–79. https://doi.org/10.1081/DDC-120025454.
Rowe C, Katstra W, Palazzolo R, Giritlioglu B, Teung P, Cima M. Multimechanism oral dosage forms fabricated by three dimensional printing™. J Control Release. 2000;66(1):11–7. https://doi.org/10.1016/s0168-3659(99)00224-2.
Katstra W, Palazzolo R, Rowe C, Giritlioglu B, Teung P, Cima M. Oral dosage forms fabricated by three dimensional printing™. J Control Release. 2000;66(1):1–9. https://doi.org/10.1016/s0168-3659(99)00225-4.
Jacob J, Beach L, West TG, Monkhouse DC, Surprenant HL. Rapidly dispersible dosage form of topiramate. US9492380B2. 2015. https://patentimages.storage.googleapis.com/e5/41/91/b8a424f306d780/US9492380.pdf
Jacob J, Caputo K, Guillot M, Sultzbaugh KJ, West TG. Rapidly dispersible dosage form of oxcarbazepine. US9314429B2. 2015. https://patentimages.storage.googleapis.com/53/eb/3b/ce838503ad2b27/US9314429.pdf
Jacob J, Coyle N, West TG, Monkhouse DC, Surprenant HL, Jain NB. Rapid disperse dosage form containing levetiracetam. US9339489B2. 2014. https://patentimages.storage.googleapis.com/c0/37/97/90136dab112bb2/US9339489.pdf
Vithani K, Goyanes A, Jannin V, Basit AW, Gaisford S, Boyd BJ. An overview of 3D printing technologies for soft materials and potential opportunities for lipid-based drug delivery systems. Pharm Res. 2019;36(1):4. https://doi.org/10.1007/s11095-018-2531-1.
Antic A, Gibson I, Hapgood K. Exploring the 3D printing binder jetting process for pharmaceutical applications. Chemeca 2018. Queenstown, New Zealand: Institution of Chemical Engineers; 2018. p. 256.
Parteli E, Schmidt J, Blumel C, Wirth KE, Peukert W, Poschel T. Attractive particle interaction forces and packing density of fine glass powders. Sci Rep. 2014;4:6227. https://doi.org/10.1038/srep06227.
Averardi A, Cola C, Zeltmann SE, Gupta N. Effect of particle size distribution on the packing of powder beds: a critical discussion relevant to additive manufacturing. Mater Today Commun. 2020;24:100964. https://doi.org/10.1016/j.mtcomm.2020.100964.
Miyanaji H, Zhang S, Yang L. A new physics-based model for equilibrium saturation determination in binder jetting additive manufacturing process. Int J Mach Tool Manu. 2018;124:1–11. https://doi.org/10.1016/j.ijmachtools.2017.09.001.
Bai Y, Wagner G, Williams CB. Effect of bimodal powder mixture on powder packing density and sintered density in binder jetting of metals. 2015 International Solid Freeform Fabrication Symposium: The University of Texas at Austin; 2015. p. 758–71.
Bai Y, Wagner G, Williams CB. Effect of particle size distribution on powder packing and sintering in binder jetting additive manufacturing of metals. J Manuf Sci E-T Asme. 2017;139(8). https://doi.org/10.1115/1.4036640.
Lu K, Hiser M, Wu W. Effect of particle size on three dimensional printed mesh structures. Powder Technol. 2009;192(2):178–83. https://doi.org/10.1016/j.powtec.2008.12.011.
Zhang J, Allardyce BJ, Rajkhowa R, Wang XG, Liu X. 3D printing of silk powder by binder jetting technique. Addit Manuf. 2021;38. https://doi.org/10.1016/j.addma.2020.101820.
Modaressi H, Garnier G. Mechanism of wetting and absorption or water droplets on sized paper: effects of chemical and physical heterogeneity. Langmuir. 2002;18(3):642–9. https://doi.org/10.1021/la0104931.
Sen K, Mehta T, Sansare S, Sharifi L, Ma AWK, Chaudhuri B. Pharmaceutical applications of powder-based binder jet 3D printing process – a review. Adv Drug Deliv Rev. 2021;113943. https://doi.org/10.1016/j.addr.2021.113943.
Bika D, Tardos GI, Panmai S, Farber L, Michaels J. Strength and morphology of solid bridges in dry granules of pharmaceutical powders. Powder Technol. 2005;150(2):104–16. https://doi.org/10.1016/j.powtec.2004.11.024.
Kougoulos E, Marziano I, Miller P. Lactose particle engineering: influence of ultrasound and anti-solvent on crystal habit and particle size. J Cryst Growth. 2010;312(23):3509–20. https://doi.org/10.1016/j.jcrysgro.2010.09.022.
Ohrem HL, Schornick E, Kalivoda A, Ognibene R. Why is mannitol becoming more and more popular as a pharmaceutical excipient in solid dosage forms? Pharm Dev Technol. 2014;19(3):257–62. https://doi.org/10.3109/10837450.2013.775154.
Sugimoto M, Matsubara K, Koida Y, Kobayashi M. The preparation of rapidly disintegrating tablets in the mouth. Pharm Dev Technol. 2001;6(4):487–93. https://doi.org/10.1081/pdt-120000287.
Sugimoto M, Narisawa S, Matsubara K, Yoshino H, Nakano M, Handa T. Development of manufacturing method for rapidly disintegrating oral tablets using the crystalline transition of amorphous sucrose. Int J Pharm. 2006;320(1-2):71–8. https://doi.org/10.1016/j.ijpharm.2006.04.004.
Sugimoto M, Maejima T, Narisawa S, Matsubara K, Yoshino H. Factors affecting the characteristics of rapidly disintegrating tablets in the mouth prepared by the crystalline transition of amorphous sucrose. Int J Pharm. 2005;296(1-2):64–72. https://doi.org/10.1016/j.ijpharm.2005.02.031.
Guy A, Dahl TC, Rogers TL. Handbook of pharmaceutical excipients. 6th ed. London, Grayslake, Washington: Pharmaceutical Press, American Pharmacists Association; 2009.
Wu W, Zheng Q, Guo X, Sun J, Liu Y. A programmed release multi-drug implant fabricated by three-dimensional printing technology for bone tuberculosis therapy. Biomed Mater. 2009;4(6):065005. https://doi.org/10.1088/1748-6041/4/6/065005.
Zhou Z, Buchanan F, Mitchell C, Dunne N. Printability of calcium phosphate: calcium sulfate powders for the application of tissue engineered bone scaffolds using the 3D printing technique. Mater Sci Eng C. 2014;38:1–10. https://doi.org/10.1016/j.msec.2014.01.027.
Goole J, Amighi K. 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems. Int J Pharm. 2016;499(1-2):376–94. https://doi.org/10.1016/j.ijpharm.2015.12.071.
Dürig T, Karan K. Binders in pharmaceutical granulation. In: Parikh DM, editor. Handbook of Pharmaceutical Granulation Technology. 4th ed. Boca Raton: CRC Press; 2021. p. 103–30.
Albertini B, Cavallari C, Passerini N, González-Rodrıguez M, Rodriguez L. Evaluation of β-lactose, PVP K12 and PVP K90 as excipients to prepare piroxicam granules using two wet granulation techniques. Eur J Pharm Biopharm. 2003;56(3):479–87. https://doi.org/10.1016/s0939-6411(03)00114-0.
Planinšek O, Pišek R, Trojak A, Srčič S. The utilization of surface free-energy parameters for the selection of a suitable binder in fluidized bed granulation. Int J Pharmaceut. 2000;207(1-2):77–88. https://doi.org/10.1016/s0378-5173(00)00535-4.
Becker D, Rigassi T, Bauer-Brandl A. Effectiveness of binders in wet granulation: a comparison using model formulations of different tabletability. Drug Dev Ind Pharm. 1997;23(8):791–808. https://doi.org/10.3109/03639049709150550.
Ziaee M, Crane NB. Binder jetting: A review of process, materials, and methods. Addit Manuf. 2019;28:781–801. https://doi.org/10.1016/j.addma.2019.05.031.
Fromm JE. Numerical calculation of the fluid dynamics of drop-on-demand jets. IBM J Res Dev. 1984;28(3):322–33. https://doi.org/10.1147/rd.283.0322.
Jang D, Kim D, Moon J. Influence of fluid physical properties on ink-jet printability. Langmuir. 2009;25(5):2629–35. https://doi.org/10.1021/la900059m.
Reis N, Derby B. Ink jet deposition of ceramic suspensions: modeling and experiments of droplet formation. MRS Proc. 2000;625:117. https://doi.org/10.1557/PROC-625-117.
Mostafaei A, Elliott AM, Barnes JE, Li FZ, Tan WD, Cramer CL, et al. Binder jet 3D printing—process parameters, materials, properties, —modeling, and challenges. Prog Mater Sci. 2021;119:100707. https://doi.org/10.1016/j.pmatsci.2020.100707.
Derby B, Reis N. Inkjet printing of highly loaded particulate suspensions. MRS Bull. 2003;28(11):815–8. https://doi.org/10.1557/mrs2003.230.
Noguera R, Lejeune M, Chartier T. 3D fine scale ceramic components formed by ink-jet prototyping process. J Eur Ceram Soc. 2005;25(12):2055–9. https://doi.org/10.1016/j.jeurceramsoc.2005.03.223.
Bussmann M, Chandra S, Mostaghimi J. Modeling the splash of a droplet impacting a solid surface. Phys Fluids. 2000;12(12):3121–32. https://doi.org/10.1063/1.1321258.
Jackson C. Aspects of aqueous pigment ink formulation: latency, dynamic surface tension, and pigment volume concentration. J Image Soc Japan. 2016;55(6):723–31. https://doi.org/10.11370/isj.55.723.
De Gans BJ, Duineveld PC, Schubert US. Inkjet printing of polymers: state of the art and future developments. Adv Mater. 2004;16(3):203–13. https://doi.org/10.1002/adma.200300385.
Kestin J, Sokolov M, Wakeham WA. Viscosity of liquid water in the range −8 °C to 150 °C. J Phys Chem Ref Data. 1978;7(3):941–8. https://doi.org/10.1063/1.555581.
C4810A - HP 11 Black Printhead. 2020. https://h10057.www1.hp.com/ecomcat/hpcatalog/specs/provisioner/99/C4810A.htm. Accessed 14 Feb 2022.
Ricoh MH5420/5440. 2017. https://industry.ricoh.com/en/-/Media/Ricoh/Sites/industry/industrialinkjet/pdf/RICOH_MH5420_5440.pdf. Accessed 14 Feb 2022.
Miyanaji H, Zhang S, Lassell A, Zandinejad AA, Yang L. Optimal process parameters for 3D printing of porcelain structures. Proc Manuf. 2016;5:870–87. https://doi.org/10.1016/j.promfg.2016.08.074.
Bai Y, Wall C, Pham H, Esker A, Williams CB. Characterizing binder–powder interaction in binder jetting additive manufacturing via sessile drop goniometry. J Manuf Sci E-T Asme. 2019;141(1). https://doi.org/10.1115/1.4041624.
Emady HN, Kayrak-Talay D, Litster JD. Modeling the granule formation mechanism from single drop impact on a powder bed. J Colloid Interf Sci. 2013;393:369–76. https://doi.org/10.1016/j.jcis.2012.10.038.
Benet LZ, Broccatelli F, Oprea TI. BDDCS applied to over 900 drugs. Aaps J. 2011;13(4):519–47. https://doi.org/10.1208/s12248-011-9290-9.
Bharate SS, Bharate SB, Bajaj AN. Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review. J Excip Food Chem. 2010;1(3):3–26.
Lipper RA, Higuchi WI. Analysis of theoretical behavior of a proposed zero-order drug delivery system. J Pharm Sci. 1977;66(2):163–4. https://doi.org/10.1002/jps.2600660207.
Yoo J, Bradbury TJ, Bebb TJ, Iskra J, Surprenant HL, West TG. Three-dimensional printing system and equipment assembly. US8888480B2. 2013. https://patentimages.storage.googleapis.com/f7/d0/c4/410780f68b7e27/US8888480.pdf
Wijshoff H. The dynamics of the piezo inkjet printhead operation. Phys Rep. 2010;491(4-5):77–177. https://doi.org/10.1016/j.physrep.2010.03.003.
European Pharmacopoeia. Water-solid Interactions: determination of sorption-desorption isotherms and of water activity (04/2019:20939). 10 ed. Strasbourg: Council Of Europe; 2019. p. 394.
Q3C Impurities: Guideline for Residual Solvents. Geneva: International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use; 1997.
Beach-Herrera LE, Boldt MF, Bradbury TJ, Cabral H, Caputo KE, Gross WR, et al. Method and system for forming a dosage form within a packaging. US20210393533A1. 2019. https://patentimages.storage.googleapis.com/68/78/18/fe5609b8ad365f/US20210393533A1.pdf.
Strondl A, Lyckfeldt O, Brodin H, Ackelid U. Characterization and control of powder properties for additive manufacturing. Jom-Us. 2015;67(3):549–54. https://doi.org/10.1007/s11837-015-1304-0.
FDA. Technical considerations for additive manufactured medical devices: Guidance for industry and Food and Drug Administration staff. Rockville: FDA; 2017.
Trenfield SJ, Awad A, Goyanes A, Gaisford S, Basit AW. 3D printing pharmaceuticals: drug development to frontline care. Trends Pharmacol Sci. 2018;39(5):440–51. https://doi.org/10.1016/j.tips.2018.02.006.
Rahman Z, Charoo NA, Kuttolamadom M, Asadi A, Khan MA. Printing of personalized medication using binder jetting 3D printer. In: Faintuch J, Faintuch S, editors. Precision Medicine for Investigators, Practitioners and Providers. 1st ed. London: Academic Press; 2020. p. 473–81.
Meteyer S, Xu X, Perry N, Zhao YF. Energy and material flow analysis of binder-jetting additive manufacturing processes. Proc Cirp. 2014;15:19–25. https://doi.org/10.1016/j.procir.2014.06.030.
Elbadawi M, Castro BM, Gavins FKH, Ong JJ, Gaisford S, Perez G, et al. M3DISEEN: A novel machine learning approach for predicting the 3D printability of medicines. Int J Pharm. 2020;590:119837. https://doi.org/10.1016/j.ijpharm.2020.119837.
Eleftheriadis GK, Genina N, Boetker J, Rantanen J. Modular design principle based on compartmental drug delivery systems. Adv Drug Deliver Rev. 2021;178:113921. https://doi.org/10.1016/j.addr.2021.113921.
Funding
The PhD project of Y.W. is fully sponsored by Mille International ApS, Hellerup, Denmark.
Author information
Authors and Affiliations
Contributions
All authors contributed to the conceptualization of this work. The first draft of the manuscript was written by Yingya Wang and revised by Jukka Rantanen and Anette Müllertz. All authors approved the final version for submission.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wang, Y., Müllertz, A. & Rantanen, J. Additive Manufacturing of Solid Products for Oral Drug Delivery Using Binder Jetting Three-Dimensional Printing. AAPS PharmSciTech 23, 196 (2022). https://doi.org/10.1208/s12249-022-02321-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/s12249-022-02321-w